Breadcrumb Navigation

Steriwave photodisinfection in the prophylaxis and treatment of COVID-19

Steriwave nasal photodisinfection has been successfully used in Canada to reduce the risk and incidence of surgical site infections.

Wichtig: Einlass gemäss 3G-Regel
Bei Kursen, Kongressen und Vorlesungen in USZ-Räumen müssen die Teilnehmenden neu zusätzlich zu den bestehenden Massnahmen ein gültiges COVID-Zertifikat vorweisen.

Standort

Universitätsspital Zürich
Nord 2, Etage C, Raum 804
Frauenklinikstrasse 24
8006 Zürich

USZ Lageplan öffnen

Datum

16.09.2021

Uhrzeit

16.00 Uhr

With more than 100,000 treatments administered over the past decade, this light-activated antimicrobial treatment rapidly and painlessly eradicates bacteria, viruses and fungi in the nose without generating microbial resistance. With the onset and escalation of the COVID-pandemic, Ondine Biomedical, the creator of Steriwave and others began studying the potential for its nasal photodisinfection to help. Results from one year of in vitro and in vivo studies of photodisinfection will be discussed.

Speaker

Nicolas G. Loebel, PhD, President and Chief Technology Officer, Ondine Research Laboratories, Inc., Bothell, WA, USA

Behandelnder Fachbereich

Klinik für Mund-, Kiefer- und Gesichtschirurgie